Publications

Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.

Author(s): Tsang TK, Du RQR, Fang VJ, Lau EHY, Chan KH, Chu DKW, Ip DKM, Peiris JSM, Leung GM, Cauchemez S, Cowling BJ|Journal: Epidemiol Infect|PMID: 38584132| July 2024

Previous studies suggest that influenza virus infection may provide temporary non-specific immunity and hence lower the risk of non-influenza respiratory…

Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.

Author(s): Patel MK, Bergeri I, Bresee JS, Cowling BJ, Crowcroft NS, Fahmy K, Hirve S, Kang G, Katz MA, Lanata CF, L'Azou Jackson M, Joshi S, Lipsitch M, Mwenda JM, Nogareda F, Orenstein WA, Ortiz JR, Pebody R, Schrag SJ, Smith PG, Srikantiah P, Subissi L, Valenciano M, Vaughn DW, Verani JR, Wilder-Smith A, Feikin DR|Journal: Vaccine|PMID: 34119350| June 2021

Phase 3 randomized-controlled trials have provided promising results of COVID-19 vaccine efficacy, ranging from 50 to 95% against symptomatic disease…

Addendum: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.

Author(s): Wu JT, Leung K, Kishore N, Niehus R, De Salazar PM, Cowling BJ, Lipsitch M, Leung GM|Journal: Nat Med|PMID: 32661399| May 2020

On 17 April 2020, the Wuhan Municipal Health Commission revised the official COVID-19 death counts in Wuhan up by 1,290…

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.

Author(s): Wu JT, Leung K, Bushman M, Kishore N, Niehus R, De Salazar PM, Cowling BJ, Lipsitch M, Leung GM|Journal: Nat Med|PMID: 32284616| March 2020

As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-19 in mainland China. Of these,…

Case-based surveillance of antimicrobial resistance with full susceptibility profiles.

Author(s): Ryu S, Cowling BJ, Wu P, Olesen S, Fraser C, Sun DS, Lipsitch M, Grad YH|Journal: JAC Antimicrob Resist|PMID: 32280945| December 2019

Surveillance of antimicrobial resistance (AMR) is essential for clinical decision-making and for public health authorities to monitor patterns in resistance…

The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology.

Author(s): Chua H, Feng S, Lewnard JA, Sullivan SG, Blyth CC, Lipsitch M, Cowling BJ|Journal: Epidemiology|PMID: 31609860| October 2019

The test-negative design is an increasingly popular approach for estimating vaccine effectiveness (VE) due to its efficiency. This review aims…

Accounting for unobserved and differential susceptible time at risk in retrospective studies: response to Dean (2019).

Author(s): Lewnard JA, Tedijanto C, Cowling BJ, Lipsitch M|Journal: Am J Epidemiol|PMID: 30689694| February 2019

Measurement of Vaccine Direct Effects Under the Test-Negative Design.

Author(s): Lewnard JA, Tedijanto C, Cowling BJ, Lipsitch M|Journal: Am J Epidemiol|PMID: 30099505| December 2018

Test-negative designs are commonplace in assessments of influenza vaccination effectiveness, estimating this value from the exposure odds ratio of vaccination…

Zika vaccine trials.

Author(s): Lipsitch M, Cowling BJ|Journal: Science|PMID: 27609872| September 2016

Utilizing syndromic surveillance data for estimating levels of influenza circulation.

Author(s): Patterson-Lomba O, Van Noort S, Cowling BJ, Wallinga J, Gomes MG, Lipsitch M, Goldstein E|Journal: Am J Epidemiol|PMID: 24748609| June 2014

The availability of weekly Web-based participatory surveillance data on self-reported influenza-like illness (ILI), defined here as self-reported fever and cough/sore…